FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

Medication Can be Given Up to Once Every 2 Months SILVER SPRING, Md., March 28, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12…